AZD-7594
Pwodwi detay
Tags pwodwi
| Gwosè pake | Disponibilite | Pri (USD) |
| 100 mg | Nan Stock | 500 |
| 500 mg | Nan Stock | 800 |
| 1g | Nan Stock | 1200 |
| Plis gwosè | Jwenn Quotes | Jwenn Quotes |
Non Chimik:
3-(5-((1R,2S)-2-(2,2-difluoropropanamido)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)propoxy)-1H-indazol -1-yl)-N-(tetrahydrofuran-3-yl)benzamid
Kòd SMILES:
O=C(NC1COCC1)C2=CC=CC(N3N=CC4=C3C=CC(O[C@H](C5=CC=C(OCCO6)C6=C5)[C@@H](NC(C( F)(F)C)=O)C)=C4)=C2
Kòd InChi:
InChI=1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-2 7-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26) 24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,2 3,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23?,29-/m0/s1
InChi kle:
ZZWJKLGCDHYVMB-QMQODZDESA-N
Mot:
AZD-7594, AZD 7594, AZD7594, AZ13189620, AZ-13189620, AZ 13189620, 1196509-60-0
Solibilite:Soluble nan DMSO
Depo:0 - 4 ° C pou kout tèm (jou a semèn), oswa -20 ° C pou tèm long (mwa).
Deskripsyon:
AZD-7594, ke yo rele tou AZ13189620, se yon modulatè reseptè glikokortikoid selektif pou respire (GCCR). AZD-7594 se nan faz II esè klinik pa AstraZeneca pou tretman opresyon modere ak modere. Li se tou nan faz I esè klinik pou tretman maladi obstriktif poumon kwonik (COPD).
Sib: GCCR
